Ray Dalio
ADPT icon

Ray Dalio’s Adaptive Biotechnologies ADPT Stock Holding History

Ray Dalio’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Sell
89,707
-175,784
-66% -$2.8M 0.01% 752
2025
Q4 		$4.31M Buy
265,491
+114,237
+76% +$1.86M 0.02% 577
2025
Q3 		$2.26M Buy
+151,254
New +$1.84M 0.01% 703

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ray Dalio's ADPT Position: Q1 2026 in Review

Ray Dalio reduced its Adaptive Biotechnologies (ADPT) stake by 66% in Q1 2026, selling an estimated $2.8M and leaving 89,707 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #752.

Ray Dalio first reported a position in ADPT in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.31M in Q4 2025. 296 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Ray Dalio held 89,707 shares of Adaptive Biotechnologies worth $1.25M as of Q1 2026.
  • Ray Dalio sold 175,784 Adaptive Biotechnologies shares in Q1 2026, an estimated $2.8M.
  • Adaptive Biotechnologies made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #752 holding.
  • Ray Dalio first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 3 quarters since.
  • Ray Dalio's Adaptive Biotechnologies position peaked at $4.31M in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.